Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Brain Neoplasms 6Recurrence 3Carcinoma, Non-Small-Cell Lung 3Neoplasms 2Neoplasm Metastasis 2Melanoma 2Skin Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Obesity 1Neuroblastoma 1Motor Activity 1Lymphoma, Follicular 1Lung Neoplasms 1Kidney Neoplasms 1Hepatitis 1Health Behavior 1Glioblastoma 1Fibrosis 1Cognition Disorders 1Child Behavior 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Behavior 1

Interventions

Blood Specimen Collection 7Pentoxifylline 4Liver Transplantation 4Magnetic Resonance Spectroscopy 3Tocopherols 2Low-Level Light Therapy 2High-Energy Shock Waves 2tremelimumab 1sonidegib 1maltodextrin 1epigallocatechin gallate 1durvalumab 1contrast agent BR1 1bavituximab 1apixaban 1alpha-Tocopherol 1Vitamin E 1Vitamin D 1User-Centered Design 1Tenofovir 1Surveys and Questionnaires 1Sunitinib 1Standard of Care 1Spermine Synthase 1Specimen Handling 1Sorafenib 1Sonazoid 1Sodium Chloride 1Sampling Studies 1Restraint, Physical 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Fibrosis × Spermine Synthase × Clear all
NCT05429190 2023-11-29

Validation of SMS Protocol for HCC Screening in High-risk Patients

Erasmus Medical Center

Unknown
470 enrolled
Gastrointestinal

Fibrosis, Hepatitis, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡